Blackstar used the phrase ..."subject to obtaining funding, by 1st Quarter of 2021." back in 2020 with regard to the trading platform. That recapitalize comment doesn't help shareholders as the company burns through their authorized share count. Meanwhile the CEO doesn't address the elephant in the room with regard to regulatory approvals in his infomercials. He can say anything and everything to promote this but until the regulatory issues are resolved they will continue to have zero revenue. Until then they will use phrases like "We believe" "We believe it may" "We intend to" "We hope that" to tease along some hope for current shareholders. The last time he mentioned the issues is in September 2023 just before this runup and before this was trading as low as $0.0001. The patent changes nothing with respect to product efficacy. It just grants them the privilege to spend money on attorneys should someone get interested in this obscure market segment.
The Company will recapitalize itself and seeks strategic partners to mainstream its platform.
We believe the Company is on the path to bringing its proposed business plan to reality. However, there can be no assurance that such regulatory approvals will be obtained in a timely manner or at all.
We believe it may take an additional six to nine months to address SEC comments and questions, and there is no assurance that we will be successful in our shares being approved or cleared for trading on our BDTP™ platform. The BDTP™ is not yet functional and may never be functional.
We intend to continue having discussions with various ATS's until we have secured an arrangement that will allow the BDTP™ platform to operate.
We currently intend to seek a contractual arrangement such as a license with an existing ATS for a quoting service, similar to the current listing of our common stock with OTC Markets Group. At this time, no ATS has committed to an arrangement.
We hope that BDTP will be operational, subject to obtaining funding, by 1st Quarter of 2021.
In July 2020, the Company presented the concept to SEC FinHub staff members for regulatory guidance and received the recommendation to apply for Alternative Trading System ("ATS") status.
Given that guidance, we are evaluating our options for finalizing the BDTP, including exploring partnerships with existing ATS's.
BlackStar will continue to seek further input from various regulatory agencies and OTC Markets on the potential functionality and regulatory aspects of the BDTP over the next several months.